Erythema chronicum migrans
||This article may be too technical for most readers to understand. (April 2011)|
|Erythema chronicum migrans|
|Classification and external resources|
An erythema migrans rash.
|ICD-10||A69.2 (ILDS A69.22)|
Erythema chronicum migrans (New Latin, literally, "chronic migrating redness") refers to the rash often (though not always) seen in the early stage of Lyme disease. It can appear anywhere from one day to one month after a tick bite. This rash does not represent an allergic reaction to the bite, but rather an actual skin infection with the Lyme bacteria, Borrelia burgdorferi sensu lato. "Erythema migrans is the only manifestation of Lyme disease in the United States that is sufficiently distinctive to allow clinical diagnosis in the absence of laboratory confirmation.". It is a pathognomonic sign: a physician-identified rash warrants an instant diagnosis of Lyme disease and immediate treatment without further testing, even by the strict criteria of the Centers for Disease Control and Prevention. These rashes are characteristic of Borrelia infections and no other pathogens are known that cause this form of rash.
A similar condition called Southern Tick Associated Rash Illness (STARI) produces a similar rash pattern although it develops quicker and is smaller. The associated infectious agent has not been determined. Antibotic treatment resolves the illness quickly.
In a 1909 meeting of the Swedish Society of Dermatology, Arvid Afzelius first presented research about an expanding, ring-like lesion he had observed. Afzelius published his work 12 years later and speculated the rash came from the bite of an Ixodes tick, meningitic symptoms and signs in a number of cases and that both sexes were affected. This rash is now known as erythema chronicum migrans, the skin rash found in early-stage Lyme disease.
In the 1920s, French physicians Garin and Bujadoux described a patient with meningoencephalitis, painful sensory radiculitis, and erythema migrans following a tick bite, and they postulated the symptoms were due to a spirochetal infection. In the 1940s, German neurologist Alfred Bannwarth described several cases of chronic lymphocytic meningitis and polyradiculoneuritis, some of which were accompanied by erythematous skin lesions.
The erythema migrans rash is classically 5 to 6.8 cm in diameter, appearing as an annular homogenous erythema (59%), central erythema (30%), central clearing (9%), or central purpura (2%). Because of the "bull's-eye" description to describe the Lyme disease rash, the condition commonly called ringworm is sometimes confused with Lyme disease. Uncommonly, EM may be less than 5 cm in diameter. Multiple painless EM rashes may occur, indicating disseminated infection.
The EM rash occurs, according to sources, in 80% to 90% of those infected with Borrelia. A systematic review of the medical literature showed 80% of patients have an expanding EM rash, at the site of the tick bite, although some patients with EM do not recall a tick bite. In endemic areas of the United States, homogeneously red rashes are more frequent.
Oral erythema migrans
Oral erythema migrans also called migratory stomatitis when extensive areas in the oral cavity mucosa are affected, or geographic tongue when confined to the dorsal and lateral aspects of the tongue mucosa, is a very common entity of unknown etiology and pathogenesis that affects 1% to 2.5% of the general population.
- Wormser GP, Dattwyler RJ, Shapiro ED, et al. (November 2006). "The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America". Clin. Infect. Dis. 43 (9): 1089–134. doi:10.1086/508667. PMID 17029130. ""pp. 1101–2 Background and Diagnosis of Erythema Migrans"
- Ogden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H (January 2008). "The rising challenge of Lyme borreliosis in Canada". Can. Commun. Dis. Rep. 34 (1): 1–19. PMID 18290267.
- Lone Star Tick a Concern @ CDC
- Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology. St. Louis: Mosby. ISBN 1-4160-2999-0.
- Lipschütz, B. (1931). "Zur Kenntnis der "Erythema chronicum migrans"". Acta dermato-venereologica (Stockholm) 12: 100–2.
- Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM (2006). "Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis". Clin. Dermatol. 24 (6): 509–20. doi:10.1016/j.clindermatol.2006.07.012. PMID 17113969.
- Weber K, Wilske B (2006). "Mini erythema migrans—a sign of early Lyme borreliosis". Dermatology (Basel) 212 (2): 113–6. doi:10.1159/000090650. PMID 16484816.
- CDC Lyme Disease Erythema Migrans Disease Retrieved May 13 2007
- Dandache P, Nadelman RB (2008). "Erythema migrans?". Infect Dis Clin North Am 22 (2): 235–60. doi:10.1016/j.idc.2007.12.012. PMID 18452799.
- Rational Clinical Examination
- Tibbles CD, Edlow JA (2007). "Does this patient have erythema migrans?". JAMA 297 (23): 2617–27. doi:10.1001/jama.297.23.2617. PMID 17579230.
- Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, Holman MS, Persing DH, Steere AC (2002). "Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans" (PDF). Ann Intern Med 136 (6): 421–8. PMID 11900494.
- Edlow JA (2002). "Erythema migrans". Med Clin North Am 86 (2): 239–60. doi:10.1016/S0025-7125(03)00085-3. PMID 11982300.
- Donta ST (2002). "Late and chronic Lyme disease". Med Clin North Am 86 (2): 341–9, vii. doi:10.1016/S0025-7125(03)00090-7. PMID 11982305.
- Cameron D, Gaito A, Narris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R, Phillips S, Meer-Scherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R; ILADS Working Group (2004). "Evidence-based guidelines for the management of Lyme disease" (PDF). Expert Rev Anti Infect Ther 2 (1 Suppl): S1–13. doi:10.1586/14789072.2.1.S1. PMID 15581390.
- Zadik Y, Drucker S, Pallmon S (Aug 2011). "Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth" (PDF). J Am Acad Dermatol 65 (2): 459–60. doi:10.1016/j.jaad.2010.04.016. PMID 21763590.